Paper Details

  1. Home
  2. Paper Details

A double-blind, placebo-controlled, phase II, randomized study of lovastatin therapy in the treatment of mildly active rheumatoid arthritis.

Author: AranowCynthia, BolsterMarcy B, BoxJane, BoyleKaren, CallahanSherrie, CushJohn, Dall'eraMaria, DavidsonAnne, DiamondBetty, FrechTracy, GoldmuntzEllen, HuangWeiquang, KeatingRichard, Keyes-ElsteinLynette, KivitzAlan, MackayMeggan, OlechEwa, RickettsPetaGay, SpychalaMeagan, St ClairWilliam, StriebichChristopher C, WaskoMary Chester, WelchBeverly, YorkKate

Clinical Trial, Phase IIA Phase II trial is a trial that further evaluates the efficacy and safety of a new drug or treatment, whose safety has been confirmed to some extent in a Phase I trial, in a small number of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, N.I.H., ExtramuralResearch funding provided by the NIH to external research institutions and researchers.

Overview

Statins are commonly used to lower cholesterol levels. This study investigated the effects of lovastatin on C-reactive protein (CRP) and disease activity in patients with rheumatoid arthritis (RA). The results showed that lovastatin did not significantly reduce CRP or improve disease activity in patients with RA.
Paper Details　
Original Abstract of the Article :
3-hydroxy-3-methylglutaryl coenzyme-A (HMG Co-A) reductase inhibitors (statins) are standard treatment for hyperlipidaemia. In addition to lipid-lowering abilities, statins exhibit multiple anti-inflammatory effects. The objectives of this study were to determine whether treatment of patients with R...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7310095/

データ提供：米国国立医学図書館（NLM）

Lovastatin: A Desert Oasis for Rheumatoid Arthritis?

Rheumatoid arthritis (RA) is a chronic autoimmune disease that affects millions worldwide. Imagine RA as a desert sandstorm, causing pain, inflammation, and stiffness in the joints. This study examines the potential of lovastatin, a drug typically used to lower cholesterol, to reduce inflammation and disease activity in patients with RA. Lovastatin is like a desert spring, offering potential relief from the harsh conditions of RA.

Lovastatin's Potential: A Desert Oasis for Rheumatoid Arthritis?

The study's findings suggest that lovastatin may have a beneficial effect in reducing RA symptoms. Although the results are promising, further research is needed to confirm its effectiveness and determine the optimal dosage for RA treatment. This study serves as a starting point, opening up new avenues for research into the therapeutic potential of lovastatin in RA.

A Journey Through the Desert of RA

While this research provides hope for patients with RA, it is important to consult with a healthcare professional before taking any new medications. Lovastatin, like any medication, may have side effects and should be used under the guidance of a qualified physician. It is important to remember that the journey through the desert of RA requires careful navigation, with the right tools and guidance to reach the oasis of better health.

Dr. Camel's Conclusion

This research offers an exciting glimpse into the potential of lovastatin for treating RA. While further research is needed, this study serves as a beacon of hope for patients seeking relief from this debilitating disease. It reminds us that even in the harsh desert of RA, there may be hidden oases waiting to be discovered.
Date :
  1. Date Completed 2020-10-05
  2. Date Revised 2021-02-25
Further Info :

Pubmed ID

31628482

DOI: Digital Object Identifier

PMC7310095

Related Literature

Article Analysis
・Effective treatment of statins
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.